drugset / Trial / NCT00321308
Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess the efficacy and safety of PF-3512676 administered in combination with pemetrexed for the treatment of patients with locally advanced or metastatic NSCLC who have failed one prior chemotherapy regimen
Timeline
- Start
- 2006-09
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | agatolimod | Oligonucleotide (other) | — | — |
| Comparator | Pemetrexed | Small molecule | 500 mg/m2 | Intravenous |